Package 68382-395-04

{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "5b244567-d037-4fbd-9e2b-ed394e1c07b4", "openfda": {"nui": ["N0000175459", "N0000175466"], "upc": ["0368382395016"], "unii": ["49717AWG6K"], "rxcui": ["312818"], "spl_set_id": ["2c3a64d5-fde2-437b-bafc-e76dd187d85a"], "pharm_class_epc": ["Nucleoside Analog Antiviral [EPC]"], "manufacturer_name": ["Zydus Pharmaceuticals USA Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "4 VIAL in 1 CARTON (68382-395-04)  / 1 POWDER, FOR SOLUTION in 1 VIAL", "package_ndc": "68382-395-04", "marketing_start_date": "20161215"}], "brand_name": "RIBAVIRIN", "product_id": "68382-395_5b244567-d037-4fbd-9e2b-ed394e1c07b4", "dosage_form": "POWDER, FOR SOLUTION", "pharm_class": ["Nucleoside Analog Antiviral [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "68382-395", "generic_name": "ribavirin", "labeler_name": "Zydus Pharmaceuticals USA Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "RIBAVIRIN", "active_ingredients": [{"name": "RIBAVIRIN", "strength": "6 g/1"}], "application_number": "ANDA207366", "marketing_category": "ANDA", "marketing_start_date": "20161215", "listing_expiration_date": "20261231"}